Advisor Group Holdings, Inc. Capricor Therapeutics, Inc. Transaction History
Advisor Group Holdings, Inc.
- $52.6 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 18,472 shares of CAPR stock, worth $116,004. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,472
Previous 9,458
95.31%
Holding current value
$116,004
Previous $93,000
96.77%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CAPR
# of Institutions
139Shares Held
12.3MCall Options Held
4.99MPut Options Held
5.52M-
Vanguard Group Inc Valley Forge, PA2.31MShares$14.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$10.2 Million0.0% of portfolio
-
State Street Corp Boston, MA1.47MShares$9.21 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA963KShares$6.05 Million0.0% of portfolio
-
Morgan Stanley New York, NY551KShares$3.46 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $153M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...